Top compounds associated with response to CHFR


Feature Type Standardized
Nominal ANOVA
mRNA MS-275 GDSC1000 pan-cancer AAC -0.02 0.7
mRNA Zebularine CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC 0.03 0.7
mRNA BMS-345541 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC -0.022 0.7
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.03 0.7
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA Cisplatin GDSC1000 pan-cancer AAC 0.013 0.7
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV